IOVA vs JPM Stock Comparison
JPM currently leads IOVA in this stock comparison, with AIQ scores of 53 vs 45. The clearest difference is quality, while IOVA has the stronger momentum profile.
What is the main difference between IOVA and JPM?
JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Iovance Biotherapeutics, Inc. vs JPMorgan Chase & Co.
JPM leads
JPM leads by 8 AIQ points, primarily on Quality and Risk Resilience, having only recently taken the lead back from IOVA. Wall Street currently favors IOVA on target upside.
Fragile: 3 of 6 evidence groups support JPM, the lead recently changed hands, and its current signal state is conflicted.
Iovance Biotherapeutics, Inc.
JPMorgan Chase & Co.
The Algovestiq AIQ Score currently favors JPM over IOVA, 53 versus 45 as of Oct 31, 2026. JPM's advantage is driven primarily by stronger quality and risk resilience, while IOVA holds the stronger momentum profile. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors IOVA. 3 of 6 covered evidence groups favor JPM today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. JPM lead: Reversed — IOVA led by 3 AIQ points 30 sessions ago; JPM now leads by 8.
Compare Iovance Biotherapeutics, Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare IOVA and JPM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality30 vs 46JPM +16
- Risk Resilience53 vs 69JPM +16
- Value34 vs 44JPM +10
- Momentum70 vs 61IOVA +9
3 of 6 evidence groups favor JPM. JPM’s edge is concentrated in quality and risk resilience; IOVA keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- 52-Week High Proximity — bullish, risk, long horizon (3.0%)
Largest factor move: Momentum +2
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
JPM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — IOVA and JPM both carry a full feed there.
The central trade-off
JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by quality and risk resilience.
IOVA (Iovance Biotherapeutics, Inc.): the counter-case, on momentum, fundamentals, technicals — but at materially higher volatility, 69.1% against 13%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
JPMJPM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
IOVAIOVA on combined revenue and EPS growth.
Value
JPMJPM on the peer-relative Value factor, by 10 points.
Momentum
IOVAIOVA on the Momentum factor, by 9 points.
Lower downside
JPMJPM on Risk Resilience, by 16 points.
Analyst upside
IOVAIOVA on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors JPM, analyst targets favor IOVA. That disagreement is the most useful thing on this page.
| Measure | IOVA | JPM | Note |
|---|---|---|---|
| Implied upside to target | +45.2% | +10.7% | IOVA has more room |
| Target dispersion | +121.9% | +32.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 9 | 11 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | JPM | 45 vs 53 |
| Fundamentals | IOVAon balance | revenue growth 39% vs -7.6%; EPS growth 42.1% vs -27.6%; TTM ROE -40.5% vs 17.9%; gross margin 116.3% vs 63.2%; operating margin -92.7% vs 28.2% — IOVA takes 3 of 5 decided legs, not all of them |
| Valuation | JPM | Value 34 vs 44 |
| Technicals | IOVA | Price vs 50-day -25.3% vs -2%; vs 200-day 156.7% vs 5.2% |
| Risk Resilience | JPM | Risk Resilience 53 vs 69 |
| Analyst expectations | IOVA | Target upside 45.2% vs 10.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IOVA and JPM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 8 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28JPM lead: Reversed — IOVA led by 3 AIQ points 30 sessions ago; JPM now leads by 8.
- Today
- JPM +8
- 45 vs 53
- 7 sessions ago
- JPM +8
- 42 vs 50
- 30 sessions ago
- IOVA +3
- 47 vs 44
- 90 sessions ago
- JPM +5
- 47 vs 52
The lead changed hands once in this window, most recently on Sep 16 when IOVA moved ahead of JPM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 2 neutral, conflicted
Only IOVA
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.10%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- 52-Week High Proximity — bullish, risk, long horizon (3.0%)
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
2 bullish / 1 bearish, conflicted
Only JPM
- BB Upper Band Breach — bearish, volatility, short horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -11.3%, AIQ 0 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.9%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1IOVA closes the Quality gap — currently 16 points behind, the largest single contributor to JPM's edge.
- 2IOVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3JPM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
IOVA leads on balance| Metric | IOVA | JPM |
|---|---|---|
| Revenue growth (YoY) | 39% | -7.6% |
| EPS growth (YoY) | 42.1% | -27.6% |
| Gross margin | 116.3% | 63.2% |
| Operating margin | -92.7% | 28.2% |
| Return on equity (TTM) | -40.5% | 17.9% |
| Debt to equity | 0.06 | 3.32 |
Performance
IOVA leads 5 of 6 windows| Metric | IOVA | JPM |
|---|---|---|
| 1 week (5 sessions) | 1.3% | 1.2% |
| 1 month (20 sessions) | -0.1% | 2.6% |
| 3 months (63 sessions) | 215.8% | -3.3% |
| 6 months (126 sessions) | 332% | 9.7% |
| Year to date | 438.9% | 5.3% |
| 1 year (252 sessions) | 558.2% | 12.9% |
Technicals
IOVA has the stronger structure| Metric | IOVA | JPM |
|---|---|---|
| RSI (14) | 61.2 | 60.9 |
| ADX (14) | 40.5 | 15 |
| Price vs 50-day | -25.3% | -2% |
| Price vs 200-day | 156.7% | 5.2% |
| Volatility (1M, annualized) | 69.1% | 13% |
Risk
JPM is the more resilient| Metric | IOVA | JPM |
|---|---|---|
| Beta | 1.22 | 0.73 |
| Sharpe ratio | 2.28 | 0.41 |
| Sortino ratio | 5.36 | 0.56 |
| Max drawdown | -39% | -15.5% |
| Current drawdown | -0.3% | -7.1% |
| Annualized volatility | 105% | 22% |
| Value at risk (95%) | -7.4% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, IOVA or JPM?
On the Algovestiq AIQ Score, JPM is the stronger of the two as of Oct 31, 2026, scoring 53 against IOVA's 45. The edge comes from quality and risk resilience. IOVA is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is IOVA or JPM the better buy right now?
JPM carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor JPM over IOVA?
The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Quality by 16 points; JPM leads Risk Resilience by 16 points; JPM leads Value by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, IOVA or JPM?
Analyst price targets imply +45.2% upside for IOVA and +10.7% for JPM, so the Street currently favors IOVA. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, IOVA or JPM?
JPM is the better-valued of the two on the peer-relative Value factor. JPM on the peer-relative Value factor, by 10 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, IOVA or JPM?
IOVA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, IOVA or JPM?
IOVA on the Momentum factor, by 9 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, IOVA or JPM?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is IOVA more profitable than JPM?
The profitability evidence is mixed: gross margin 116.3% vs 63.2%; operating margin -92.7% vs 28.2%; ttm roe -40.5% vs 17.9%. IOVA leads on one measure and JPM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is JPM's lead over IOVA getting stronger or weaker?
JPM lead: Reversed — IOVA led by 3 AIQ points 30 sessions ago; JPM now leads by 8. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands once in that window, most recently on 2026-09-16, when IOVA moved ahead of JPM.
What would change the IOVA vs JPM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IOVA closes the Quality gap — currently 16 points behind, the largest single contributor to JPM's edge; IOVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; JPM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about IOVA and JPM?
IOVA: 4 bullish / 1 bearish / 2 neutral, conflicted. JPM: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IOVA is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).
Compare IOVA and JPM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.